Numinus Wellness Inc. (NUMIF)

Market Cap	11.16M
Revenue (ttm)	16.48M
Net Income (ttm)	-18.66M
Shares Out	n/a
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	71,362
Open	0.0215
Previous Close	0.0225
Day's Range	0.0215 - 0.0225
52-Week Range	0.0092 - 0.0800
Beta	2.48
RSI	49.03
Earnings Date	Jul 8, 2025

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assist...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: NUMIF

Financial Performance

In 2023, Numinus Wellness's revenue was 23.18 million, an increase of 256.95% compared to the previous year's 6.49 million. Losses were -30.26 million, -32.59% less than in 2022.

Financial numbers in CAD